Salluh Jorge I F, Póvoa Pedro
*D'Or Institute for Reasearch and Education, Rio de Janeiro, Brazil †PostGraduate Program in Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil ‡Polyvalent Intensive Care Unit, Hospital de Sao Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal §NOVA Medical School, CEDOC, New University of Lisbon, Lisbon, Portugal.
Shock. 2017 Jan;47(1S Suppl 1):47-51. doi: 10.1097/SHK.0000000000000704.
For decades, corticosteroids are proposed as adjuvant therapies for severe infections. Despite mounting evidence from randomized controlled trials, there is still an intense debate regarding the role of systemic low-dose corticosteroids as a part of the treatment of septic shock. In the present article, we review the current literature and detail aspects on the pathophysiologic rationale, the current evidence, actual practice, and future directions on this topic.
几十年来,皮质类固醇一直被提议作为严重感染的辅助治疗方法。尽管随机对照试验提供了越来越多的证据,但关于全身性低剂量皮质类固醇作为脓毒性休克治疗一部分的作用仍存在激烈争论。在本文中,我们回顾了当前的文献,并详细阐述了关于这一主题的病理生理原理、现有证据、实际应用及未来方向等方面。